Abstract:Purpose. Neuropilin-2 (NRP-2) is a coreceptor for vascular endothelial growth factor (VEGF) on endothelial cells. NRP-2 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) cells relative to nonmalignant ductal epithelium. This study determined the role of NRP-2 in PDAC cells.Experimental Design. NRP-2 expression was reduced in PDAC cells with stable short-hairpin RNA (shRNA) transfection. Western blotting was done to evaluate signaling intermediates. Migration and invasion studies were carried out in Boyden chambers. Anchorage-independent growth was assessed by soft-agar colony formation. In vivo growth was evaluated using murine subcutaneous and orthotopic xenograft models. Immunohistochemical analysis evaluated in vivo proliferation and angiogenesis.Results. shRNA-NRP-2 decreased NRP-2 levels without affecting neuropilin-1 levels. Akt activation was decreased in clones with reduced NRP-2 (shRNA-NRP-2). shRNA-NRP-2 cells showed decreased migration, invasion, and anchorage-independent growth compared with control cells. In vitro proliferation rates were similar in control- and shRNA-transfected cells. Subcutaneous and orthotopic xenografts from shRNA-transfected cells were significantly smaller than those resulting from control-transfected cells (P < 0.05). Furthermore, shRNA-NRP-2 tumors exhibited less cellular proliferation and decreased microvascular area relative to control tumors (P < 0.05). Constitutive expression of the angiogenic mediator Jagged-1 was reduced in shRNA-NRP-2 cells, whereas vascular endothelial growth factor levels were unchanged.Conclusion. Reduction of NRP-2 expression in PDAC cells decreased survival signaling, migration, invasion, and ability to grow under anchorage-independent conditions. In vivo, reduction of NRP-2 led to decreased growth of xenograft tumors and decreased vascular area, which was associated with decreased Jagged-1 levels. NRP-2 is a potential therapeutic target on PDAC cells.

Adenovirus-mediated NDRG2 Inhibits the Proliferation of Human Renal Cell Carcinoma Cell Line OS-RC-2 in Vitro

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498

Influence of NDRG2 on proliferation and apoptosis of human esophageal cell line Eca-109

Effect of NDRG2 on proliferation of breast cancer cells

Inhibition of Endothelial Cell Proliferation and Tumor Angiogenesis by Up-Regulating NDRG2 Expression in Breast Cancer Cells

Up-Regulation Of Pvhl Along With Down-Regulation Of Hif-L Alpha By Ndrg2 Expression Attenuates Proliferation And Invasion In Renal Cancer Cells

Antitumor Effect of Recombinant NDRG2 Protein on Tumor Cells

Suppression of Invasion and Metastasis of Prostate Cancer Cells by Overexpression of NDRG2 Gene.

NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Nidus Vespae Protein Inhibiting Proliferation of Hepg2 Hepatoma Cells Through Extracellular Signal-Regulated Kinase Signaling Pathways and Inducing G(1) Cell Cycle Arrest

The Effect of Adenovirus-Conjugated Ndrg2 on P53-Mediated Apoptosis of Hepatocarcinoma Cells Through Attenuation of Nucleotide Excision Repair Capacity

Expression of NDRG2 in Clear Cell Renal Cell Carcinoma.

Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma

Study on mechanism of NDRG2 inhibiting the adhesion potential of hepatocellular carcinoma cells by regulating CD24

Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion

NDRG2 in rat liver regeneration: role in proliferation and apoptosis.

Ndrg2 Inhibits Hepatocellular Carcinoma Adhesion, Migration and Invasion by Regulating Cd24 Expression

Efficacy of adenovirus-mediated CD gene combined with prodrugs and α-IFN for treatment of human renal clear carcinoma